Beta-hydroxy-beta-methylbutyrate supplementation in health and disease: a systematic review of randomized trials (Q28299062)

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Year-long changes in protein metabolism in elderly men and women supplemented with a nutrition cocktail of beta-hydroxy-beta-methylbutyrate (HMB), L-arginine, and L-lysine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

The effects of an amino acid supplement on glucose homeostasis, inflammatory markers, and incretins after laparoscopic gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Nutritional effect of oral supplement enriched in beta-hydroxy-beta-methylbutyrate, glutamine and arginine on resting metabolic rate after laparoscopic gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

The effects of beta-hydroxy-beta-methylbutyrate (HMB) and HMB/creatine supplementation on indices of health in highly trained athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Signaling pathways initiated by beta-hydroxy-beta-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Attenuation of depression of muscle protein synthesis induced by lipopolysaccharide, tumor necrosis factor, and angiotensin II by beta-hydroxy-beta-methylbutyrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-alpha and angiotensin II by beta-hydroxy-beta-methylbutyrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Effect of beta-hydroxy-beta-methylbutyrate, arginine, and lysine supplementation on strength, functionality, body composition, and protein metabolism in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Free acid gel form of β-hydroxy-β-methylbutyrate (HMB) improves HMB clearance from plasma in human subjects compared with the calcium HMB salt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Vitamin D status affects strength gains in older adults supplemented with a combination of β-hydroxy-β-methylbutyrate, arginine, and lysine: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Beta-hydroxy-beta-methylbutyrate ingestion, Part I: effects on strength and fat free mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

β-Hydroxy-β-methylbutyrate reduces myonuclear apoptosis during recovery from hind limb suspension-induced muscle fiber atrophy in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Effect of beta-hydroxy-beta-methylbutyrate (HMB) on protein metabolism in whole body and in selected tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Creatine and beta-hydroxy-beta-methylbutyrate (HMB) additively increase lean body mass and muscle strength during a weight-training program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Beta-hydroxy-beta-methylbutyrate (HMB) stimulates myogenic cell proliferation, differentiation and survival via the MAPK/ERK and PI3K/Akt pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Effects of β-hydroxy-β-methylbutyrate treatment in different types of skeletal muscle of intact and septic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Effects of amino acids supplement on physiological adaptations to resistance training

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Effects of calcium beta-hydroxy-beta-methylbutyrate (HMB) supplementation during resistance-training on markers of catabolism, body composition and strength.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Beta-hydroxy-beta-methylbutyrate supplementation in critically ill trauma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Exercise-induced muscle damage is not attenuated by beta-hydroxy-beta-methylbutyrate and alpha-ketoisocaproic acid supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Beta-hydroxy-beta-methylbutyrate supplementation reduces tumor growth and tumor cell proliferation ex vivo and prevents cachexia in Walker 256 tumor-bearing rats by modifying nuclear factor-kappaB expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

β-Hydroxy-β-methylbutyrate modifies human peripheral blood mononuclear cell proliferation and cytokine production in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Short-term beta-hydroxy-beta-methylbutyrate supplementation does not reduce symptoms of eccentric muscle damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Nutritional supplementation of the leucine metabolite beta-hydroxy-beta-methylbutyrate (hmb) during resistance training.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

β-Hydroxy-β-methylbutyrate (HMβ) supplementation stimulates skeletal muscle hypertrophy in rats via the mTOR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Metabolic and functional effects of beta-hydroxy-beta-methylbutyrate (HMB) supplementation in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

The effect of HMB supplementation on body composition, fitness, hormonal and inflammatory mediators in elite adolescent volleyball players: a prospective randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Supplementation with a combination of beta-hydroxy-beta-methylbutyrate (HMB), arginine, and glutamine is safe and could improve hematological parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Mechanism of attenuation by beta-hydroxy-beta-methylbutyrate of muscle protein degradation induced by lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Nutrition modulation of cachexia/proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Beta-hydroxy beta-methylbutyrate (HMB) supplementation does not influence the urinary testosterone: epitestosterone ratio in healthy males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Beta-hydroxy-beta-methylbutyrate (HMB) supplementation does not affect changes in strength or body composition during resistance training in trained men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by beta-hydroxy-beta-methylbutyrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Effects of nine weeks of beta-hydroxy-beta- methylbutyrate supplementation on strength and body composition in resistance trained men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Mechanisms of skeletal muscle atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Effect of a specialized amino acid mixture on human collagen deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Effects of beta-hydroxy-beta-methylbutyrate (HMB) on exercise performance and body composition across varying levels of age, sex, and training experience: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Intention-to-treat. What is the question?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

Potential antiproteolytic effects of L-leucine: observations of in vitro and in vivo studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z

HMB supplementation: clinical and athletic performance-related effects and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-013-1592-Z